Amanda Atanasio

Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a Phase 1 study.

P. Hellings, P. Gevaert, G. Yancopoulos, 2021, The Journal of allergy and clinical immunology.

Targeting immunodominant Bet v 1 epitopes with monoclonal antibodies prevents the birch allergic response.

A. Murphy, G. Yancopoulos, Jennifer Jones, 2021, The Journal of allergy and clinical immunology.

Biologics as novel therapeutics for the treatment of allergy: Challenges and opportunities

N. Stahl, M. Sleeman, J. Orengo, 2022, Frontiers in Allergy.

Production of large, defined genome modifications in rats by targeting rat embryonic stem cells

E. Chiao, C. Romano, W. Auerbach, 2022, Stem cell reports.

Diverse Phenotypes and Specific Transcription Patterns in Twenty Mouse Lines with Ablated LincRNAs

J. Rinn, G. Yancopoulos, G. Droguett, 2015, PloS one.

C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice

C. Siao, A. Murphy, G. Yancopoulos, 2016, Scientific Reports.

Generation of fertile and fecund F0 XY female mice from XY ES cells

C. Siao, G. Yancopoulos, J. Kuno, 2015, Transgenic Research.

Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy

Kaitlyn M. Gayvert, M. Wipperman, J. Orengo, 2024, Allergy.